RE: Potential, Potential, Potential.27 Sep 2018 20:20
Wheelds, I don't share your optimism re China at this stage. This is what the accounts said:
"& Planned launch by BY-HEALTH of a number of Fruitflow based products in the Chinese market progressing well, with two studies successfully completed, one study currently ongoing at a clinical site and three further planned human studies confirmed by BY-HEALTH. The two completed studies (a human study and an animal study) showed excellent results in use for Fruitflow .
The six studies outlined are being conducted at BY-HEALTH's sole expense, a substantial investment in the Fruitflow based products which BY-HEALTH plans to launch in China. Studies conducted in China are needed to obtain 'blue cap' health claim status for dietary supplements, as required by the China Food and Drug Administration (CFDA), with BY-HEALTH intending to make the relevant submission to the CFDA by the end of 2018.
& The MOU for a research and collaboration agreement for Fruitflow between the Company and BY-HEALTH, a £3bn listed Chinese dietary supplement business, remains on track with the research project now scheduled to take place in the first half of 2019, effectively being a seventh BY-HEALTH study"
My interpretation of these three paragraphs is that there is a degree of bureaucracy to overcome before any products are ready to sell and are any products anywhere near ready? Provexis also has financial commitment under the MOU so how's that going to be funded?
I don't know about the big hype around the H&B launch.There's a bewildering array of products to chose from and a small but devoted following of Fruitflow. They will need to push the story which, to date, has been a spectacular failure.
I really feel that your optimism knows no limit!